Literature DB >> 15580009

Indocyanine green angiography-guided photodynamic therapy for treatment of chronic central serous chorioretinopathy: a pilot study.

P Mahesh Shanmugam, Manisha Agarwal.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15580009     DOI： 10.1097/00006982-200412000-00031

Source DB:  PubMed          Journal:  Retina        ISSN： 0275-004X            Impact factor:   4.256


× No keyword cloud information.
  3 in total

1.  Half-dose vs one-third-dose photodynamic therapy for chronic central serous chorioretinopathy.

Authors:  R Uetani; Y Ito; K Oiwa; K Ishikawa; H Terasaki
Journal:  Eye (Lond)       Date:  2012-05       Impact factor: 3.775

2.  Long-term results of half-dose photodynamic therapy for chronic central serous chorioretinopathy with contrast sensitivity changes.

Authors:  S H Karakus; B Basarir; E Y Pinarci; E U Kirandi; A Demirok
Journal:  Eye (Lond)       Date:  2013-03-22       Impact factor: 3.775

3.  Improved thickness measurement method for choroidal hyperpermeability in central serous chorioretinopathy.

Authors:  Xing-Wang Chen; Fang-Yuan Han; Gang Su; Le Pan; Shan-Jun Cai
Journal:  Int J Ophthalmol       Date:  2020-09-18       Impact factor: 1.779
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.